TGF-βRI 억제제인 벤조트리아졸에서 유도된 α,β-불포화 아미드계 화합물

본 발명은 TGF-βR1 억제제의 구조가 식(I)으로 표시되는 벤조트리아졸에 의해 유도된 α,β-불포화 아미드계 화합물 또는 이의 약학적으로 허용 가능한 염을 공개한다. A benzotriazole-derived ± and ²-unsaturated amide compound used as TGF-²R1 inhibitor or a pharmaceutically acceptable salt thereof, the structure of the compound being as shown in formula (I)....

Full description

Saved in:
Bibliographic Details
Main Authors SUN FEI, CHEN SHUHUI, LU JIANYU, HU GUOPING, LI JIAN, WU LIFANG, DING CHARLES Z
Format Patent
LanguageKorean
Published 20.02.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 본 발명은 TGF-βR1 억제제의 구조가 식(I)으로 표시되는 벤조트리아졸에 의해 유도된 α,β-불포화 아미드계 화합물 또는 이의 약학적으로 허용 가능한 염을 공개한다. A benzotriazole-derived ± and ²-unsaturated amide compound used as TGF-²R1 inhibitor or a pharmaceutically acceptable salt thereof, the structure of the compound being as shown in formula (I).
AbstractList 본 발명은 TGF-βR1 억제제의 구조가 식(I)으로 표시되는 벤조트리아졸에 의해 유도된 α,β-불포화 아미드계 화합물 또는 이의 약학적으로 허용 가능한 염을 공개한다. A benzotriazole-derived ± and ²-unsaturated amide compound used as TGF-²R1 inhibitor or a pharmaceutically acceptable salt thereof, the structure of the compound being as shown in formula (I).
Author WU LIFANG
CHEN SHUHUI
LU JIANYU
HU GUOPING
SUN FEI
DING CHARLES Z
LI JIAN
Author_xml – fullname: SUN FEI
– fullname: CHEN SHUHUI
– fullname: LU JIANYU
– fullname: HU GUOPING
– fullname: LI JIAN
– fullname: WU LIFANG
– fullname: DING CHARLES Z
BookMark eNrjYmDJy89L5WSID3F30z23KchT4c20rW8WzAGhuTsUXm9a8mbhhrddO14vW_NmasubhTveTJ_wpmWOwps5C173t7yeMEfh3Eadc5t0X2_reNu_5u3MKQpAZa_X73g9ec6rzS0KQIG3U1e-XrOHh4E1LTGnOJUXSnMzKLu5hjh76KYW5MenFhckJqfmpZbEewcZGRhaGhgYmluaWjoaE6cKAGh1WSQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20190017959A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20190017959A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:59:58 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20190017959A3
Notes Application Number: KR20197001025
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190220&DB=EPODOC&CC=KR&NR=20190017959A
ParticipantIDs epo_espacenet_KR20190017959A
PublicationCentury 2000
PublicationDate 20190220
PublicationDateYYYYMMDD 2019-02-20
PublicationDate_xml – month: 02
  year: 2019
  text: 20190220
  day: 20
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies MEDSHINE DISCOVERY INC
GENFLEET THERAPEUTICS (SHANGHAI) INC
RelatedCompanies_xml – name: GENFLEET THERAPEUTICS (SHANGHAI) INC
– name: MEDSHINE DISCOVERY INC
Score 3.148971
Snippet 본 발명은 TGF-βR1 억제제의 구조가 식(I)으로 표시되는 벤조트리아졸에 의해 유도된 α,β-불포화 아미드계 화합물 또는 이의 약학적으로 허용 가능한 염을 공개한다. A benzotriazole-derived ± and ²-unsaturated amide compound used...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TGF-βRI 억제제인 벤조트리아졸에서 유도된 α,β-불포화 아미드계 화합물
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190220&DB=EPODOC&locale=&CC=KR&NR=20190017959A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUy1AO2NSdZNNjVM0zUBdnV0E5PNU3VNUlNMzBPNUhPNwWtzfP3MPEJNvCJMI5gYcmB7YcDnhJaDD0cE5qhkYH4vAZfXBYhBLBfw2spi_aRMoFC-vVuIrYsatHcMrN2MjAzUXJxsXQP8Xfyd1Zydbb2D1PyCIHKg1Gdq6cjMwApsSJuD8oNrmBNoX0oBcqXiJsjAFgA0L69EiIEpO1-YgdMZdveaMAOHL3TKG8iE5r5iEYb4EHc33XObgjwV3kzb-mbBHBCau0Ph9aYlbxZueNu14_WyNW-mtrxZuOPN9AlvWuYovJmz4HV_y-sJcxTObdQ5t0n39baOt_1r3s6cogBU9nr9jteT57za3KIAFHg7deXrNXtEGZTdXEOcPXSBLo2HB0y8dxCyt4zFGFjy8vNSJRgUzAwSzU2NEpOTElNSTdIsExOT08wSU9MskxOB9XVisqEkgww-k6TwS0szcIG44I3dBjIMLCVFpamywKq5JEkOHKIAO9WujQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUy1AO2NSdZNNjVM0zUBdnV0E5PNU3VNUlNMzBPNUhPNwWtzfP3MPEJNvCJMI5gYcmB7YcDnhJaDD0cE5qhkYH4vAZfXBYhBLBfw2spi_aRMoFC-vVuIrYsatHcMrN2MjAzUXJxsXQP8Xfyd1Zydbb2D1PyCIHKg1Gdq6cjMwApsZJuD8oNrmBNoX0oBcqXiJsjAFgA0L69EiIEpO1-YgdMZdveaMAOHL3TKG8iE5r5iEYb4EHc33XObgjwV3kzb-mbBHBCau0Ph9aYlbxZueNu14_WyNW-mtrxZuOPN9AlvWuYovJmz4HV_y-sJcxTObdQ5t0n39baOt_1r3s6cogBU9nr9jteT57za3KIAFHg7deXrNXtEGZTdXEOcPXSBLo2HB0y8dxCyt4zFGFjy8vNSJRgUzAwSzU2NEpOTElNSTdIsExOT08wSU9MskxOB9XVisqEkgww-k6TwS8szcHqE-PrE-3j6eUszcIGkwJu8DWQYWEqKSlNlgdV0SZIcOHQBmFmxgA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TGF-%CE%B2RI+%EC%96%B5%EC%A0%9C%EC%A0%9C%EC%9D%B8+%EB%B2%A4%EC%A1%B0%ED%8A%B8%EB%A6%AC%EC%95%84%EC%A1%B8%EC%97%90%EC%84%9C+%EC%9C%A0%EB%8F%84%EB%90%9C+%CE%B1%2C%CE%B2-%EB%B6%88%ED%8F%AC%ED%99%94+%EC%95%84%EB%AF%B8%EB%93%9C%EA%B3%84+%ED%99%94%ED%95%A9%EB%AC%BC&rft.inventor=SUN+FEI&rft.inventor=CHEN+SHUHUI&rft.inventor=LU+JIANYU&rft.inventor=HU+GUOPING&rft.inventor=LI+JIAN&rft.inventor=WU+LIFANG&rft.inventor=DING+CHARLES+Z&rft.date=2019-02-20&rft.externalDBID=A&rft.externalDocID=KR20190017959A